A new Lancet review concludes that mRNA COVID-19 vaccines neither persist indefinitely in the body nor become part of our DNA ...

New England Biolabs (NEB®) has launched the NEBNext Companion Module for Oxford Nanopore Technologies Direct RNA Sequencing.

New England Biolabs (NEB), a world leader in the discovery and production of enzymes for molecular biology applications, has launched the NEBNext Companion Module for Oxford Nanopore Technologies ...

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...

Merck enters new agreement with ADAP Crisis Task Force to improve access and care for people living with HIV: Rahway, New Jersey Wednesday, July 1, 2026, 14:00 Hrs [IST] Merck, kn ...

Algonomics announced on July 9 that its anticancer gene therapy platform, "RZ-002," has received a patent registration decision in the United States.

FDA Drug Approvals and Regulatory Updates The table below is a review of notable updates that occurred in June 2026 for investigational products in development (not an inclusive list). Click on the ...

Merck , known as MSD outside of the United States and Canada, announced today that new data from its research pipeline for HIV treatment and prevention will be presented at the 26th International AIDS ...

Not every sales pitch for a reverse mortgage should be worth your time. People aged 62 or older are the target demographic for reverse mortgages — a tool that can tap their home’s equity for cash. But ...

With a reverse mortgage, people aged 55 and older can tap their home equity for cash. In most cases, a reverse mortgage is used to improve liquidity during retirement when people are on a fixed income ...

However, current enzymes still produce off-target effects, so researchers have been exploring ways to extend the capabilities ...